Dynamic circulating biomarkers for predicting adverse events in PRaG therapy: a pooled analysis and model construction from PRaG series clinical trials
This study successfully delineated the real-world safety profile of PRaG therapy and identified a distinct set of dynamic circulating biomarkers strongly associated with moderate-to-severe AEs. The established non-invasive prediction model offers an effective tool for clinical early warning and proactive management in PRaG patients.
Authors
- Wei-wu Chen
- Xiang-rong Zhao
- Mei-ling Xu
- Yue-hong Kong
- Peng-fei Xing
- Shi-cheng Li
- Jun-jun Zhang
- Li-yuan Zhang
- Qian Yin
Institutions
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1007/s00262-025-04292-w
- Primary Topic
- Advanced Causal Inference Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Soochow University
- State Key Laboratory of Radiation Medicine and Protection